Landis Lum
Family Medicine · Kailua, HINPI 1730228842
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 312 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 15 manufacturers, the largest accounting for just 20.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $4,299, 2.9 times the $1,459 reported in 2019. Among family medicine clinicians in HI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 312 payments — averaging $52.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$3K
- Alkermes, Inc.$2K
- Neurocrine Biosciences, Inc.$2K
- Indivior Inc.$2K
- AbbVie$1K
- Otsuka America Pharmaceutical, Inc.$1K
- plus $4K from 9 others
What the payments were for
- Food & beverage$16,25199%
- Education$1411%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 63 | $3,325 |
| Alkermes, Inc. | 39 | $2,294 |
| Neurocrine Biosciences, Inc. | 36 | $2,204 |
| Indivior Inc. | 53 | $2,191 |
| AbbVie(2 entities) | 22 | $1,281 |
| Otsuka America Pharmaceutical, Inc. | 27 | $1,201 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 20 | $1,025 |
| Johnson & Johnson | 10 | $973 |
| E.r. Squibb & Sons, L.L.C. | 13 | $691 |
| Vanda Pharmaceuticals Inc. | 14 | $374 |
| Sunovion Pharmaceuticals Inc. | 3 | $345 |
| Lundbeck LLC | 8 | $183 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $106 |
| Novartis | 2 | $106 |
| Janssen Scientific Affairs, LLC | 1 | $94 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$3,358
- ARISTADA$2,753
- INGREZZA$1,474
- UZEDY$975
- ABILIFY MAINTENA$741
- Austedo XR$725
- AUSTEDO$714
- CAPLYTA$711
- INVEGA SUSTENNA$666
- VRAYLAR$608
- ARISTADA INITIO$585
- SUBLOCADE$502
- PERSERIS$486
- LATUDA$345
- COBENFY$285
- ABILIFY ASIMTUFII$272
- DALVANCE$250
- SPRAVATO$250
- INVEGA TRINZA$248
- VIVITROL$235
How this compares
$16,393 in reported general payments places this provider in the 95th percentile of 376 family medicine providers in Hawaii.
Other family medicine in Kailua
- Stuart LernerKailua$18K
- Jonathan GriffinKailua$2K
- Brian StolleyKihei$126K
- Vicente RamoHonolulu$34K
- Edward AlqueroWaipahu$24K
- Noelani HobbsWaipahu$23K
- Rainier Dennis BautistaLihue$23K
- Choon YeoHonolulu$20K
- Buddy FesterlingHilo$20K
- Roy KogaHilo$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.